keyword
https://read.qxmd.com/read/38516780/clinical-guideline-for-preimplantation-genetic-testing-in-inherited-cardiac-diseases
#21
JOURNAL ARTICLE
Job A J Verdonschot, Debby M E I Hellebrekers, Vanessa P M van Empel, Malou Heijligers, Sonja de Munnik, Edith Coonen, Jos C M F Dreesen, Arthur van den Wijngaard, Han G Brunner, Masoud Zamani Esteki, Stephane R B Heymans, Christine E M de Die-Smulders, Aimée D C Paulussen
BACKGROUND: Preimplantation genetic testing (PGT) is a reproductive technology that selects embryos without (familial) genetic variants. PGT has been applied in inherited cardiac disease and is included in the latest American Heart Association/American College of Cardiology guidelines. However, guidelines selecting eligible couples who will have the strongest risk reduction most from PGT are lacking. We developed an objective decision model to select eligibility for PGT and compared its results with those from a multidisciplinary team...
March 22, 2024: Circulation. Genomic and Precision Medicine
https://read.qxmd.com/read/38515138/cardiovascular-disease-in-alpha-1-antitrypsin-deficiency-an-observational-study-assessing-the-role-of-neutrophil-proteinase-activity-and-the-suitability-of-validated-screening-tools
#22
JOURNAL ARTICLE
E Sapey, L E Crowley, R G Edgar, D Griffiths, S Samanta, H Crisford, C E Bolton, J R Hurst, R A Stockley
BACKGROUND: Alpha 1 Antitrypsin Deficiency (AATD) is a rare, inherited lung disease which shares features with Chronic Obstructive Pulmonary Disease (COPD) but has a greater burden of proteinase related tissue damage. These proteinases are associated with cardiovascular disease (CVD) in the general population. It is unclear whether patients with AATD have a greater risk of CVD compared to usual COPD, how best to screen for this, and whether neutrophil proteinases are implicated in AATD-associated CVD...
March 21, 2024: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/38513726/maturity-onset-diabetes-of-the-young-mody-in-search-of-ideal-diagnostic-criteria-and-precise-treatment
#23
REVIEW
Ksenija Zečević, Špela Volčanšek, Niki Katsiki, Manfredi Rizzo, Tanja Miličević Milardović, Anca Pantea Stoian, Maciej Banach, Emir Muzurović
Maturity-onset diabetes of the young (MODY) is a spectrum of clinically heterogenous forms of monogenic diabetes mellitus characterized by autosomal dominant inheritance, onset at a young age, and absence of pancreatic islets autoimmunity. This rare form of hyperglycemia, with clinical features overlapping with type 1 and type 2 diabetes mellitus, has 14 subtypes with differences in prevalence and complications occurrence which tailor therapeutic approach. MODY phenotypes differ based on the gene involved, gene penetrance and expressivity...
March 19, 2024: Progress in Cardiovascular Diseases
https://read.qxmd.com/read/38508323/cardiovascular-pathology-inheritance-and-prognosis-in-a-familial-cohort-of-loeys-dietz-type-iii
#24
JOURNAL ARTICLE
Robert T Kay, Pishoy Gouda, Robert C Welsh
INTRODUCTION: Loeys-Dietz syndrome (LDS) is a heritable disease that is the result of dysregulation of the transforming growth factor beta (TGFβ) pathway. The pathogenic variants associated with the condition are linked to aortic aneurysms and dissections along with other cardiovascular and non-cardiovascular abnormalities. LDS type III is associated with pathogenic variants in the SMAD3 gene responsible for signally in the TGFβ pathway. Most of the current knowledge of LDS stems from studies of LDS I and II patient with limited data on large cohorts of LDS III patients...
March 18, 2024: International Journal of Cardiology
https://read.qxmd.com/read/38506054/regional-variation-in-cardiovascular-genes-enables-a-tractable-genome-editing-strategy
#25
JOURNAL ARTICLE
Vikki A Krysov, Rachel H Wilson, Nicholas S Ten, Nathan Youlton, Hannah N De Jong, Shirley Sutton, Yong Huang, Chloe M Reuter, Megan E Grove, Matthew T Wheeler, Euan A Ashley, Victoria N Parikh
BACKGROUND: To realize the potential of genome engineering therapeutics, tractable strategies must be identified that balance personalized therapy with the need for off-the-shelf availability. We hypothesized that regional clustering of pathogenic variants can inform the design of rational prime editing therapeutics to treat the majority of genetic cardiovascular diseases with a limited number of reagents. METHODS: We collated 2435 high-confidence pathogenic/likely pathogenic (P/LP) variants in 82 cardiovascular disease genes from ClinVar...
March 20, 2024: Circulation. Genomic and Precision Medicine
https://read.qxmd.com/read/38495940/beyond-acute-infection-molecular-mechanisms-underpinning-cardiovascular-complications-in-long-covid
#26
REVIEW
Roba Hamed Mostafa, Ahmed Moustafa
SARS-CoV-2, responsible for the global COVID-19 pandemic, has manifested significant cardiovascular implications for the infected population. These cardiovascular repercussions not only linger beyond the initial phase of illness but have also been observed in individuals who remain asymptomatic. This extended and pervasive impact is often called the post-acute COVID-19 syndrome (PACS) or "Long COVID". With the number of confirmed global cases approaching an alarming 756 million, the multifaceted challenges of Long COVID are undeniable...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38490313/sudden-death-with-cardiac-involvement-in-a-neonate-with-carnitine-acylcarnitine-translocase-deficiency
#27
Dongfang Qiao, Jiayu Jing, Cui Zhang, Sihao Du, Xiaohui Tan, Xia Yue
A female neonate born with normal Apgar scores at 38+2 weeks of gestational age unexpectedly passed away within less than 30 hours after birth. The situation mirrors her brother's earlier demise within 24 hours post-delivery, suggesting a possible genetic disorder. A gross examination revealed widespread cyanosis and distinct yellowish changes on the cardiac ventricles. Histopathological analysis disclosed lipid accumulation in the liver, heart, and kidney. Tandem mass spectrometry detected elevated levels of 10 amino acids and 14 carnitines in cardiac blood...
March 13, 2024: Cardiovascular Pathology: the Official Journal of the Society for Cardiovascular Pathology
https://read.qxmd.com/read/38488965/hypertrophic-cardiomyopathy
#28
REVIEW
Jason N Dungu, Amy Hardy-Wallace, Anthony D Dimarco, Henry O Savage
PURPOSE OF REVIEW: Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac condition with potential for severe complications including sudden cardiac death. Early diagnosis allows appropriate risk stratification and prompt intervention to minimise the potential for adverse outcomes. The implications of poorly coordinated screening are significant, either missing relatives at high-risk or burdening low-risk individuals with a diagnosis associated with reduced life expectancy. We aim to guide clinicians through the diagnostic pathway through to novel treatment options...
March 15, 2024: Current Heart Failure Reports
https://read.qxmd.com/read/38482263/co-existence-of-cyp2c19-1-2-and-abcb1c-3435-ct-genotype-has-a-potential-impact-on-clinical-outcome-in-cad-patients-treated-with-clopidogrel
#29
JOURNAL ARTICLE
K A Nestorovska, Z Naumovska, M Staninova Stojovska, Z Sterjev, A Dimovski, Lj Suturkova
Clopidogrel, is a standard treatment in the prevention of major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD). Clopidogrel response is highly variable, mainly due to the presence of polymorphisms in the genes involved in drug metabolism. The aim of this study was to evaluate the association between the presence of the ABCB1 C3435T and CYP2C19* 2 polymorphism and the clinical outcome in patients with CAD treated with clopidogrel. A total of 96 patients with CAD were included in the study...
December 2023: Balkan Journal of Medical Genetics: BJMG
https://read.qxmd.com/read/38481246/analysis-of-disease-characteristics-of-a-large-patient-cohort-with-congenital-generalized-lipodystrophy-from-the-middle-east-and-north-africa
#30
JOURNAL ARTICLE
Saif Al Yaarubi, Afaf Alsagheir, Azza Al Shidhani, Somaya Alzelaye, Nadia Alghazir, Imad Brema, Hussain Alsaffar, Mohammed Al Dubayee, Awad Alshahrani, Yasmine Abdelmeguid, Omneya M Omar, Najya Attia, Elham Al Amiri, Jamal Al Jubeh, Albandari Algethami, Haya Alkhayyat, Azad Haleem, Mouza Al Yahyaei, Ines Khochtali, Saleha Babli, Ahmed Nugud, Nandu Thalange, Sarah Albalushi, Nadia Hergli, Asma Deeb, Majid Alfadhel
BACKGROUND: Congenital generalized lipodystrophy (CGL) is a rare inherited disease characterized by a near-total absence of adipose tissue and is associated with organ system abnormalities and severe metabolic complications. Here, we have analyzed the disease characteristics of the largest CGL cohort from the Middle East and North Africa (MENA) who have not received lipodystrophy-specific treatment. METHODS: CGL was diagnosed clinically by treating physicians through physical assessment and supported by genetic analysis, fat loss patterns, family history, and the presence of parental consanguinity...
March 13, 2024: Orphanet Journal of Rare Diseases
https://read.qxmd.com/read/38464671/long-term-efficacy-and-safety-of-cardiac-genome-editing-for-catecholaminergic-polymorphic-ventricular-tachycardia
#31
JOURNAL ARTICLE
Oliver M Moore, Yuriana Aguilar-Sanchez, Satadru K Lahiri, Mohit M Hulsurkar, J Alberto Navarro-Garcia, Tarah A Word, Joshua A Keefe, Dean Barazi, Elda M Munivez, Charles T Moore, Vaidya Parthasarathy, Jaysón Davidson, William R Lagor, So Hyun Park, Gang Bao, Christina Y Miyake, Xander H T Wehrens
INTRODUCTION: Heterozygous autosomal-dominant single nucleotide variants in RYR2 account for 60% of cases of catecholaminergic polymorphic ventricular tachycardia (CPVT), an inherited arrhythmia disorder associated with high mortality rates. CRISPR/Cas9-mediated genome editing is a promising therapeutic approach that can permanently cure the disease by removing the mutant RYR2 allele. However, the safety and long-term efficacy of this strategy have not been established in a relevant disease model...
January 2024: The journal of cardiovascular aging
https://read.qxmd.com/read/38456071/facing-ethical-concerns-in-the-age-of-precise-gene-therapy-outlook-on-inherited-arrhythmias
#32
EDITORIAL
Federico Carbone, Fabrizio Montecucco
This editorial, comments on the article by Spartalis et al published in the recent issue of the World Journal of Cardiology . We here provide an outlook on potential ethical concerns related to the future application of gene therapy in the field of inherited arrhythmias. As monogenic diseases with no or few therapeutic options available through standard care, inherited arrhythmias are ideal candidates to gene therapy in their treatment. Patients with inherited arrhythmias typically have a poor quality of life, especially young people engaged in agonistic sports...
February 26, 2024: World Journal of Cardiology
https://read.qxmd.com/read/38451266/first-degree-atrioventricular-block-in-hypertrophic-cardiomyopathy-patients-an-easy-and-worthy-prognostic-marker
#33
JOURNAL ARTICLE
Ana Filipa Amador, Catarina Martins da Costa, João Da Silva Santos, Cláudia Camila Dias, Elisabete Martins
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease. Recently, a connection has been observed between the presence of first-degree atrioventricular block (FDAVB) and cardiovascular outcomes, although the pathophysiology of this association remains poorly understood. Considering the period 2000-2023, we retrospectively included HCM patients at sinus rhythm at the first appointment and sought possible interactions of FDAVB (defined as PR interval >200 ms) with different clinical and imaging variables and with the occurrence of cardiovascular events, including atrial fibrillation (AF)...
March 6, 2024: Monaldi Archives for Chest Disease
https://read.qxmd.com/read/38450455/the-developmental-origins-of-health-and-disease-and-intergenerational-inheritance-a-scoping-review-of-multigenerational-cohort-studies
#34
REVIEW
Jie Tan, Zifang Zhang, Lijing L Yan, Xiaolin Xu
Epidemiologic research has increasingly acknowledged the importance of developmental origins of health and disease (DOHaD) and suggests that prior exposures can be transferred across generations. Multigenerational cohorts are crucial to verify the intergenerational inheritance among human subjects. We carried out this scoping review aims to summarize multigenerational cohort studies' characteristics, issues, and implications and hence provide evidence to the DOHaD and intergenerational inheritance. We adopted a comprehensive search strategy to identify multigenerational cohorts, searching PubMed, EMBASE, and Web of Science databases from the inception of each dataset to June 20th, 2022, to retrieve relevant articles...
March 7, 2024: Journal of Developmental Origins of Health and Disease
https://read.qxmd.com/read/38449779/a-rare-case-report-of-type-1-congenital-disorders-of-glycosylation-with-acute-decompensated-heart-failure-and-the-incidental-discovery-of-congenital-disorders-of-glycosylation-associated-dilated-cardiomyopathy-and-acute-myocarditis
#35
Woo Sze Yang, Suchi Grover, Emma Smith, Joseph B Selvanayagam
BACKGROUND: Congenital disorders of glycosylation (CDG) are rare genetically inherited defects leading to enzyme deficiency or malfunction in the glycosylation pathway. Normal glycosylation is essential to the development of normal cardiac anatomy and function. Congenital disorders of glycosylation-related cardiomyopathy are often the first manifestation detected in early life and may lead to sudden cardiac death. Approximately one-fifth of CDG types are related to cardiac diseases that include cardiomyopathy, rhythm disturbances, pericardial effusions, and structural heart disease...
March 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38446445/deep-learning-augmented-ecg-analysis-for-screening-and-genotype-prediction-of-congenital-long-qt-syndrome
#36
JOURNAL ARTICLE
River Jiang, Christopher C Cheung, Marta Garcia-Montero, Brianna Davies, Jason Cao, Damian Redfearn, Zachary M Laksman, Steffany Grondin, Joseph Atallah, Carolina A Escudero, Julia Cadrin-Tourigny, Shubhayan Sanatani, Christian Steinberg, Jacqueline Joza, Robert Avram, Rafik Tadros, Andrew D Krahn
IMPORTANCE: Congenital long QT syndrome (LQTS) is associated with syncope, ventricular arrhythmias, and sudden death. Half of patients with LQTS have a normal or borderline-normal QT interval despite LQTS often being detected by QT prolongation on resting electrocardiography (ECG). OBJECTIVE: To develop a deep learning-based neural network for identification of LQTS and differentiation of genotypes (LQTS1 and LQTS2) using 12-lead ECG. DESIGN, SETTING, AND PARTICIPANTS: This diagnostic accuracy study used ECGs from patients with suspected inherited arrhythmia enrolled in the Hearts in Rhythm Organization Registry (HiRO) from August 2012 to December 2021...
April 1, 2024: JAMA Cardiology
https://read.qxmd.com/read/38430092/cardiac-specific-deletion-of-scn8a-mitigates-dravet-syndrome-associated-sudden-death-in-adults
#37
JOURNAL ARTICLE
D Ryan King, Mustafa Demirtas, Mikhail Tarasov, Heather L Struckman, Xiaolei Meng, Drew Nassal, Nicolae Moise, Alec Miller, Dennison Min, Andrew M Soltisz, Midhun N K Anne, Patrícia A Alves Dias, Jacy L Wagnon, Seth H Weinberg, Thomas J Hund, Rengasayee Veeraraghavan, Przemysław B Radwański
BACKGROUND: Sudden unexpected death in epilepsy (SUDEP) is a fatal complication experienced by otherwise healthy epilepsy patients. Dravet syndrome (DS) is an inherited epileptic disorder resulting from loss of function of the voltage-gated sodium channel, NaV 1.1, and is associated with particularly high SUDEP risk. Evidence is mounting that NaV s abundant in the brain also occur in the heart, suggesting that the very molecular mechanisms underlying epilepsy could also precipitate cardiac arrhythmias and sudden death...
February 15, 2024: JACC. Clinical Electrophysiology
https://read.qxmd.com/read/38425313/fusion-imaging-for-guidance-of-pulmonary-arteriovenous-malformation-embolisation-with-minimal-radiation-and-contrast-exposure
#38
JOURNAL ARTICLE
Catalina Vargas-Acevedo, Ernesto Mejia, Jenny E Zablah, Gareth J Morgan
Hereditary haemorrhagic telangiectasia is an inherited disorder characterised by vascular dysplasia that leads to the development of arteriovenous malformations. Pulmonary arteriovenous malformations occur in approximately 30% of patients with haemorrhagic telangiectasia. Given the complex characteristics of haemorrhagic telangiectasia lesions, the application of three-dimensional fusion imaging holds significant promise for procedural guidance and decrease in contrast and radiation dosing. We reviewed all patients who underwent transcatheter approach for pulmonary arteriovenous malformation occlusion with fusion image guidance from June 2018 to September 2023 from a single centre...
March 1, 2024: Cardiology in the Young
https://read.qxmd.com/read/38420265/corrigendum-case-report-four-cases-of-cardiac-sarcoidosis-in-patients-with-inherited-cardiomyopathy-a-phenotypic-overlap-co-existence-of-two-rare-cardiomyopathies-or-a-second-hit-disease
#39
Hans Ebbinghaus, Laura Ueberham, Daniela Husser-Bollmann, Andreas Bollmann, Ingo Paetsch, Cosima Jahnke, Ulrich Laufs, Borislav Dinov
[This corrects the article DOI: 10.3389/fcvm.2023.1328802.].
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38419512/structural-and-functional-impact-of-adrenoceptor-beta-1-gene-polymorphism-in-patients-with-hypertrophic-cardiomyopathy-and-response-to-beta-blocker-therapy
#40
JOURNAL ARTICLE
Damla Raimoglou, Cemil İzgi, Rasim Enar, M Hakan Karpuz, Bilgehan Karadağ, Barış İktimur, Utku Raimoğlu, Ali Uğur Soysal, Osman Aykan Kargın, Mehmet Güven, Namina Malikova, Elif Çıtak, Ece Yurtseven, Eser Durmaz
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a genetically inherited cardiac disorder with diverse clinical presentations. Adrenergic activity, primarily mediated through beta-adrenoceptors, plays a central role in the clinical course of HCM. Adrenergic stimulation increases cardiac contractility and heart rate through beta-1 adrenoceptor activation. Beta-blocker drugs are recommended as the primary treatment for symptomatic HCM patients to mitigate these effects. METHODS: This prospective study aimed to investigate the impact of common ADRB-1 gene polymorphisms, specifically serine-glycine at position 49 and arginine-glycine at position 389, on the clinical and structural aspects of HCM...
March 2024: Anatolian Journal of Cardiology
keyword
keyword
43794
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.